Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

ADPT holding history

Adaptive Biotechnologies Corp in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADPT overviewAll 13F holders of ADPTFull Q2 2026 holdings

Shares (Q2 2026)
21,450
Value
$460.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ADPT by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202621,450$460.1K<0.1%−4,300−16.7%ReducedHolders
Q1 202625,750$357.4K<0.1%−60,300−70.1%ReducedHolders
Q4 202586,050$1.40M<0.1%−150−0.2%ReducedHolders
Q3 202586,200$1.29M<0.1%−4,400−4.9%ReducedHolders
Q2 202590,600$1.06M<0.1%−1,250−1.4%ReducedHolders
Q1 202591,850$682.4K<0.1%+3,400+3.8%AddedHolders
Q4 202488,450$530.3K<0.1%+6,725+8.2%AddedHolders
Q3 202481,725$418.4K<0.1%−4,500−5.2%ReducedHolders
Q2 202486,225$312.1K<0.1%+28,100+48.3%AddedHolders
Q1 202458,125$186.6K<0.1%+11,150+23.7%AddedHolders
Q4 202346,975$230.2K<0.1%−6,900−12.8%ReducedHolders
Q3 202353,875$293.6K<0.1%−29,400−35.3%ReducedHolders
Q2 202383,275$558.8K<0.1%+29,550+55.0%AddedHolders
Q1 202353,725$474.4K<0.1%+15,325+39.9%AddedHolders
Q4 202238,400$293.4K<0.1%−3,150−7.6%ReducedHolders
Q3 202241,550$296.0K<0.1%+1,385+3.4%AddedHolders
Q2 202240,165$325.0K<0.1%+15,370+62.0%AddedHolders
Q1 202224,795$344.0K<0.1%+6,850+38.2%AddedHolders
Q4 202117,945$504.0K<0.1%+1,160+6.9%AddedHolders
Q3 202116,785$571.0K<0.1%+875+5.5%AddedHolders
Q2 202115,910$650.0K<0.1%+525+3.4%AddedHolders
Q1 202115,385$619.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.